# | Title | Journal | Year | Citations |
---|
1 | Hepatitis B virus epidemiology, disease burden, treatment, and current and emerging prevention and control measures | Journal of Viral Hepatitis | 2004 | 2,202 |
2 | Spontaneous viral clearance following acute hepatitis C infection: a systematic review of longitudinal studies | Journal of Viral Hepatitis | 2006 | 715 |
3 | Global surveillance and control of hepatitis C | Journal of Viral Hepatitis | 1999 | 687 |
4 | Transient elastography: a new surrogate marker of liver fibrosis influenced by major changes of transaminases | Journal of Viral Hepatitis | 2007 | 573 |
5 | Peginterferon alpha-2a (40 kDa): an advance in the treatment of hepatitis B e antigen-positive chronic hepatitis B | Journal of Viral Hepatitis | 2003 | 427 |
6 | Global surveillance and control of hepatitis C. Report of a WHO Consultation organized in collaboration with the Viral Hepatitis Prevention Board, Antwerp, Belgium | Journal of Viral Hepatitis | 1999 | 424 |
7 | Performance of Acoustic Radiation Force Impulse imaging for the staging of liver fibrosis: a pooled meta‐analysis | Journal of Viral Hepatitis | 2012 | 397 |
8 | The present and future disease burden of hepatitis C virus (HCV) infection with today's treatment paradigm | Journal of Viral Hepatitis | 2014 | 372 |
9 | Alanine aminotransferase‐based algorithms of liver stiffness measurement by transient elastography (Fibroscan) for liver fibrosis in chronic hepatitis B | Journal of Viral Hepatitis | 2009 | 363 |
10 | Lamivudine in late pregnancy to prevent perinatal transmission of hepatitis B virus infection: a multicentre, randomized, double‐blind, placebo‐controlled study | Journal of Viral Hepatitis | 2009 | 327 |
11 | World-wide epidemiology of HBeAg-negative chronic hepatitis B and associated precore and core promoter variants | Journal of Viral Hepatitis | 2002 | 323 |
12 | Virologic factors associated with failure to passive–active immunoprophylaxis in infants born to HBsAg‐positive mothers | Journal of Viral Hepatitis | 2012 | 300 |
13 | The clinical significance of surface antigen variants of hepatitis B virus | Journal of Viral Hepatitis | 1997 | 299 |
14 | Aetiology, clinical course and outcome of sporadic acute viral hepatitis in pregnancy* | Journal of Viral Hepatitis | 2003 | 265 |
15 | Properties of the hepatitis C virus core protein: a structural protein that modulates cellular processes | Journal of Viral Hepatitis | 2000 | 262 |
16 | Lamivudine treatment during pregnancy to prevent perinatal transmission of hepatitis B virus infection | Journal of Viral Hepatitis | 2003 | 261 |
17 | Hepatitis B‐related hepatocellular carcinoma: epidemiological characteristics and disease burden | Journal of Viral Hepatitis | 2009 | 252 |
18 | Occult hepatitis B virus infection and its clinical implications | Journal of Viral Hepatitis | 2002 | 250 |
19 | Age and platelet count: a simple index for predicting the presence of histological lesions in patients with antibodies to hepatitisC virus | Journal of Viral Hepatitis | 1997 | 247 |
20 | Does hepatitis B virus (HBV) genotype influence the clinical outcome of HBV infection? | Journal of Viral Hepatitis | 1999 | 229 |
21 | Hepatitis C: an epidemiological review | Journal of Viral Hepatitis | 2002 | 224 |
22 | Fulminant liver failure from acute autochthonous hepatitis E in France: description of seven patients with acute hepatitis E and encephalopathy | Journal of Viral Hepatitis | 2007 | 222 |
23 | Expert opinion on the treatment of patients with chronic hepatitis C | Journal of Viral Hepatitis | 2009 | 215 |
24 | Historical epidemiology of hepatitis C virus (HCV) in selected countries | Journal of Viral Hepatitis | 2014 | 211 |
25 | Biochemical markers of liver fibrosis in patients infected by hepatitis C virus: longitudinal validation in a randomized trial | Journal of Viral Hepatitis | 2002 | 199 |
26 | Sensitivity and specificity of third-generation hepatitis C virus antibody detection assays: an analysis of the literature | Journal of Viral Hepatitis | 2001 | 197 |
27 | Hepatitis B virus: significance of genotypes | Journal of Viral Hepatitis | 2005 | 196 |
28 | Fatigue in patients with chronic hepatitis C | Journal of Viral Hepatitis | 2002 | 191 |
29 | Sofosbuvir plus ribavirin in Japanese patients with chronic genotype 2 HCV infection: an open‐label, phase 3 trial | Journal of Viral Hepatitis | 2014 | 191 |
30 | Safety and efficacy of lamivudine in patients with severe acute or fulminant hepatitis B, a multicenter experience | Journal of Viral Hepatitis | 2006 | 189 |
31 | Novel controlled attenuation parameter for noninvasive assessment of steatosis using Fibroscan®: validation in chronic hepatitis C | Journal of Viral Hepatitis | 2012 | 182 |
32 | Recent advances in Hepatitis E Virus | Journal of Viral Hepatitis | 2010 | 179 |
33 | Relationship of genotypes of hepatitis B virus to mutations, disease progression and response to antiviral therapy | Journal of Viral Hepatitis | 2005 | 174 |
34 | Control of hepatitis B virus at the level of transcription | Journal of Viral Hepatitis | 2010 | 172 |
35 | Regulatory elements of hepatitis B virus transcription | Journal of Viral Hepatitis | 2002 | 170 |
36 | Prevalence of anti-hepatitis E virus antibodies in different Indian animal species | Journal of Viral Hepatitis | 2001 | 169 |
37 | The impact of hepatitis C virus infection on survival in dialysis patients: meta-analysis of observational studies | Journal of Viral Hepatitis | 2007 | 169 |
38 | HCV burden of infection in Egypt: results from a nationwide survey | Journal of Viral Hepatitis | 2012 | 168 |
39 | Occult hepatitis B virus infection: a covert operation | Journal of Viral Hepatitis | 2010 | 163 |
40 | Low uptake of treatment for hepatitis C virus infection in a large community‐based study of inner city residents | Journal of Viral Hepatitis | 2009 | 162 |
41 | Coinfection with hepatitis B and C or B, C and δ viruses results in severe chronic liver disease and responds poorly to terferon‐a treatment | Journal of Viral Hepatitis | 1995 | 161 |
42 | Strategies to manage hepatitis C virus (HCV) disease burden | Journal of Viral Hepatitis | 2014 | 161 |
43 | Hepatocellular carcinoma: role of hepatitis B and hepatitis C viruses proteins in hepatocarcinogenesis | Journal of Viral Hepatitis | 2004 | 160 |
44 | Treating hepatitis C: current standard of care and emerging direct‐acting antiviral agents | Journal of Viral Hepatitis | 2012 | 160 |
45 | Silymarin treatment of viral hepatitis: a systematic review | Journal of Viral Hepatitis | 2005 | 155 |
46 | The role of chemokines as inflammatory mediators in chronic hepatitis C virus infection | Journal of Viral Hepatitis | 2007 | 155 |
47 | Exacerbation of chronic hepatitis B infection after delivery | Journal of Viral Hepatitis | 2008 | 153 |
48 | Enhanced Liver Fibrosis (ELF) test accurately identifies liver fibrosis in patients with chronic hepatitis C | Journal of Viral Hepatitis | 2011 | 153 |
49 | Is chronic hepatitis B being undertreated in the United States? | Journal of Viral Hepatitis | 2011 | 153 |
50 | Suppression of hepatitis C virus by the flavonoid quercetin is mediated by inhibition of NS3 protease activity | Journal of Viral Hepatitis | 2012 | 153 |